Guanze Medical Information Industry (Holding) (HKG:2427) expects a maximum profit attributable to the owners of 17.5 million yuan for 2024, lower than 27.6 million yuan from 2023, a Tuesday Hong Kong bourse filing said.
The medical imaging company attributed the expected decrease to a reduction in the average selling price of the medical imaging films sold during the reporting period, resulting in the dip in gross profits.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。